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BACKGROUND: Among patients with multiple chronic
conditions, there is increasing appreciation of the
complex interrelatedness of diseases. Previous studies
have focused on the prevalence and economic burden
associated with multiple chronic conditions, much less
is known about the mortality rate associated with
specific combinations of multiple diseases.
OBJECTIVE: Measure the mortality rate in combina-
tions of 11 chronic conditions.
DESIGN: Cohort study of veteran health care users.
PARTICIPANTS: Veterans between 55 and 64 years that
used Veterans Health Administration health care ser-
vices between October 1999 and September 2000.
MEASUREMENTS: Patients were identified as having
one or more of the following: COPD, diabetes, hyper-
tension, rheumatoid arthritis, osteoarthritis, asthma,
depression, ischemic heart disease, dementia, stroke,
and cancer. Mutually exclusive combinations of disease
based on these conditions were created, and 5-year
mortality rates were determined.
RESULTS: There were 741,847 persons included. The
numberin each groupby a countofconditions was:none=
217,944 (29.34%); 1=221,111 (29.8%); 2=175,228
(23.6%); 3=86,447 (11.7%); and 4+=41,117 (5.5%). The
5-year mortality rate by the number of conditions was:
none=4.1%; 1=6.0%; 2=7.8%; 3=11.2%; 4+=16.7%.
Amongcombinationswiththesamenumberofconditions,
there was significant variability in mortality rates.
CONCLUSIONS: Patients with multiple chronic condi-
tions have higher mortality rates. Because there was
significant variation in mortality across clusters with
the same number of conditions, when studying patients
with multiple coexisting illnesses, it is important to
understand not only that several conditions may be
present but that specific conditions can differentially
impact the risk of mortality.
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INTRODUCTION
Diseases are often described and studied as if they occur in
isolation of other disease states, yet many individuals have
multiple chronic conditions. Cooccurrence of various chronic
conditions can have unexpected consequences on disability,
1
lead to deficiencies in care,
2 and impact the benefit of clinical
practice guidelines.
3 Yet, little isknown about theoverall impact
on mortality of specific combinations of chronic conditions.
The increasing prevalence of multiple coexisting chronic
diseases with age is a phenomenon that makes sense from a
biological and clinical basis and has been described by several
investigators. For example, in The Netherlands, more than
60% of persons between 60 and 79 years old have more then
one chronic condition, and the average number of chronic
conditions in this group is 2.4.
4 In the United States, for
persons older than 65 years, the average number of chronic
conditions is 2.3, and the prevalence of persons with more
than one chronic condition is 64.7%.
5 In addition, patients
with more chronic conditions have higher health care expen-
ditures. Again, in persons in the United States over 65 years of
age, the average annual expenditures for those with four or
more chronic conditions was $13,973, and among those with
three chronic conditions, expenditures were $4,701.
5 For
persons receiving care through the Veterans Health Adminis-
tration (VHA), the average annual cost was $9,277 for those
with three or more chronic conditions and was $3,366 in those
with two chronic conditions.
6 These studies show that there is
a substantial proportion of older patients that have multiple
chronic conditions, and these patients have higher health care
expenditures.
It remains unclear whether there are specific disease groups
or clusters that are associated with increased risk of mortality
among persons with multiple chronic diseases. There are
several recent examples of how the Charlson index and other
risk indices, as well as identification of individual diseases,
have been used to successfully predict mortality.
7–16 In
addition, we generally know how individual diseases increase
the risk of mortality, but whether specific combinations of
diseases have an additive or multiplicative effect on overall
mortality when present with other chronic diseases is not well
understood. The objective of this study was to describe the
5-year mortality rates across patients with multiple chronic
conditions.
403MATERIALS AND METHODS
The national Veterans Affairs (VA) inpatient, outpatient, and
mortality databases were used to conduct a cohort study to
examine the risk of mortality associated with clusters of chronic
diseases. The study population was US veterans using the VHA
health care system between the age of 55 and 64 years. As of
April 2000, there were approximately 4.4 million veterans that
received health care services through VHA.
17 The VHA main-
tains databases of all encounters for patients receiving care in
the VHA health care system or through contract services with
other providers. We used care provided at VHA facilities as well
as care provided through contracted services to identify chronic
conditions for patients included in this analysis. Information on
inpatient admissions, outpatient encounters, and dates of
death are available in the databases.
Cohort
The cohort used in the analysis was all veterans with at least
one health care contact with the VA system between October 1,
1999 and September 30, 2000. Veterans between the ages of
55 and 64 years of age during this 12-month period were
included in the analysis. The cohort was followed until
September 30, 2004.
Disease Clusters
Patients were identified as having one or more of the following
conditions based on ICD-9 codes: COPD, diabetes, hyperten-
sion, rheumatoid arthritis, osteoarthritis, asthma, depression,
ischemic heart disease, dementia, stroke, and cancer. These
chronic diseases were chosen based on the list of priority
conditions—conditions that are prevalent and high cost in the
United States—from the Agency for Health care Research and
Quality (AHRQ) and the Centers for Medicare and Medicaid
Services (CMS). The ICD-9 codes used to identify the condi-
tions were based on the AHRQ Clinical Classification System
(Appendix).
18
Based on inpatient and outpatient encounters within the VA
health care system in 2000, patients were categorized into
mutually exclusive groups of chronic diseases. Persons were
defined as having one of the chronic conditions if they had any
diagnosis code for the condition during the 1-year time period.
The diagnostic codes were combined to create mutually
exclusive combinations of the chronic diseases so that persons
would only be included in one chronic disease combination.
Persons without a diagnosis for any of the conditions were
categorized into a “none of the selected conditions” group.
Mortality
Deaths occurring during the 5-year period following identifi-
cation of the cohort were determined. Both inpatient data and
the Beneficiary Identification and Records Locator System
(BIRLS) data were used to identify all deaths that occurred
during the follow-up period. The BIRLS data have been
reported to capture between 90 and 95% of veterans that
die.
19,20 Date of death was assigned on the basis of discharge
date for deaths that occurred in the hospital. For deaths not
identified in the inpatient data, the date of death was the date
reported in the BIRLS database.
Analysis
Patients were classified into mutually exclusive disease clus-
ters based on their diagnosis codes during the initial 12-month
period. The proportion of patients in each mutually exclusive
cluster was determined. Patients were grouped into the
following categories according to the number of diseases in
their cluster: none; one; two; three; or four or more.
We present data in the tables for clusters that included more
than 1,000 patients. The cumulative 5-year mortality rates and
95% confidence intervals were determined for each cluster and
forthe fourcategoriesbasedona count ofthenumberof diseases
in a cluster. Cumulative 5-year mortality rates were adjusted for
age by standardizing each cluster to the age of the overall cohort.
RESULTS
A total of 741,847 patients between 55 and 64 years had at
least one VA health care encounter between October 1, 1999
and September 30, 2000. There were two groups combined
that contained 43.9% of the population. There were 217,944
(29.4%) patients identified as not having any of the selected
conditions and 107,732 (14.5%) identified as having hyperten-
sion and none of the other selected conditions. The top five two
cluster groupings all included hypertension as one of the
conditions and were: hypertension+diabetes (6.4%); heart
disease+hypertension (3.8%); hypertension+osteoarthritis
(3.2%); hypertension+COPD (1.6%); and cancer+hypertension
(1.0%). Among those conditions with more than 1,000 persons,
hypertension was one of the conditions in each of the clusters
that included three or four conditions.
When grouping the clusters by the number of conditions,
the majority of the patients included in this analysis had either
none of the selected conditions (29.4%) or only a single
condition by itself (29.8%). Thus, there was 40.8% of the
population that had a cluster of diseases (i.e., two or more
conditions), with a decreasing proportion in each group as the
number of conditions increased (two conditions=23.6%; three
conditions=11.7%; four or more conditions=5.5%).
Table 1. Five-Year Mortality Rate Among Patients with only a Single
Condition or None of the Conditions
5-year mortality rate
Number Crude
(%)
Age
adjusted
(%)
95% CI (%)
Osteoarthritis 25,231 2.75 2.77 (2.56, 2.97)
Asthma 3,399 3.18 3.13 (2.54, 3.71)
Hypertension 107,732 3.81 3.81 (3.70, 3.93)
None of the
selected conditions
217,944 4.11 4.14 (4.06, 4.22)
Depression 10,922 4.38 4.66 (4.19, 5.13)
Rheumatoid
arthritis
1,694 5.96 6.05 (4.90, 7.20)
Ischemic heart
disease
16,898 6.18 6.18 (5.81, 6.54)
Diabetes 24,158 7.06 7.07 (6.75, 7.39)
Stroke 2,023 9.34 9.24 (7.99, 10.50)
COPD 15,540 13.15 13.08 (12.55, 13.61)
Dementia 2,197 14.75 15.07 (13.55, 16.60)
Cancer 10,489 22.26 22.46 (21.65, 23.26)
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period, which equates to an overall 5-year mortality rate of
7.1%. The mortality rate was lowest among those with none
of the selected diseases (4.1%) and increased as the number of
conditions increased. Compared to patients with none of the
selected conditions, the risk of death during the follow-up
period for each of the other groups was: one condition risk ratio
(RR)=1.45 (95% CI, 1.41–1.49); two conditions RR=1.88 (95%
CI, 1.83–1.93); three conditions RR=2.72 (95% CI, 2.65–2.80);
and four or more conditions RR=4.07 (95% CI, 3.95–4.19).
Among those identified with only a single condition, there
was nearly a tenfold difference in the lowest to highest
mortality rate. The age-adjusted, 5-year mortality rate ranged
from 2.77% for osteoarthritis to 22.46% for cancer (Table 1).
There were a total of 23 clusters that included only two
conditions. The age-adjusted, 5-year mortality rate among
the two condition clusters ranged from 2.94% for hyperten-
sion+osteoarthritis to 40.41% for cancer+COPD (Table 2).
Interestingly, when osteoarthritis was present in a two-condi-
tion group, the 5-year mortality rate was lower in the two-
condition cluster than the mortality rate in the condition by
itself. For example, the 5-year mortality rate for individuals
with hypertension alone was 3.81%, whereas in those with
hypertension and osteoarthritis, the rate was 2.94%. Not
surprisingly, the presence of cancer in a cluster was associated
with higher 5-year mortality rates, of the three two-condition
clusters with a mortality greater than 20%, each of them
included cancer as one of the conditions.
Similar to the two-condition clusters, there was significant
variability in the 5-year mortality rate among the three-
condition clusters. The 5-year mortality rate ranged from
4.2% for hypertension+depression+osteoarthritis to 34.6%
for cancer+hypertension+COPD (Table 3). Among those con-
ditions with mortality rates greater than 15%, each included
either COPD or cancer as one of the conditions.
There were seven four-condition clusters that included more
than 1,000 individuals. Each of the clusters included ischemic
heart disease, whereas all but one included hypertension, and
all but two included diabetes. The 5-year mortality rate ranged
from 9.4% for ischemic heart disease+hypertension+diabetes+
osteoarthritis to 22.3% for ischemic heart disease+hypertension+
diabetes+COPD (Table 4). For the clusters that included
ischemic heart disease, hypertension, and diabetes, the fourth
condition in the cluster influences the overall 5-year mortality
rate. The mortality rates for these clusters with respect to the
fourth condition were: osteoarthritis=9.4%, depression=
12.7%, stroke=16.8%; cancer=22.0%; and COPD=22.3%.
DISCUSSION
In this analysis, we found that the presence of chronic
conditions in veterans between the ages of 55 and 64 years is
high, and a significant number of these individuals have two or
more conditions. Not surprisingly, the presence of more
conditions was associated with a higher risk of 5-year mortal-
ity. However, there was a wide range in the mortality rates
across clusters with the same number of conditions, indicating
the presence of specific diseases within a cluster impacted the
risk of 5-year mortality differently.
Previous studies, both on a veteran cohort
6 and on a sample of
the general U.S. population,
5 found that costs increased dramat-
ically as the number of chronic conditions increased. These
previous studies did not look at the risk of mortality associated
with chronic conditions. We found a similar pattern with respect
to mortality in that as the number of chronic conditions
Table 2. Five-Year Mortality Rate Among Patients with Two Conditions
Cluster 5-year mortality rate
Number Crude
(%)
Age
adjusted (%)
95% CI (%)
Hypertension and osteoarthritis 2,088 2.94 2.94 2.72, 3.15
Depression and osteoarthritis 23,692 2.83 3.03 2.18, 3.88
Asthma and hypertension 2,418 3.39 3.34 2.62, 4.05
Ischemic heart disease and osteoarthritis 2,845 3.87 3.81 3.11, 4.52
Diabetes and osteoarthritis 3,652 4.85 4.84 4.15, 5.54
Hypertension and rheumatoid arthritis 1,144 4.90 4.91 3.66, 6.16
Depression and hypertension 6,410 5.16 5.44 4.81, 6.06
Hypertension and ischemic heart disease 28,154 5.58 5.66 5.38, 5.93
Diabetes and hypertension 47,568 6.28 6.28 6.07, 6.50
Depression and diabetes 1,440 6.46 6.50 5.12, 7.88
Depression and ischemic heart disease 1,030 6.50 6.91 5.26, 8.56
Asthma and COPD 1,576 7.99 8.04 6.70, 9.38
Hypertension and stroke 3,679 8.70 8.75 7.83, 9.68
COPD and osteoarthritis 3,106 9.53 9.49 8.46, 10.52
Diabetes and ischemic heart disease 1,274 11.40 11.38 10.56, 12.21
Depression and COPD 5,790 11.07 11.60 9.70, 13.49
COPD and hypertension 11,883 12.22 12.14 11.55, 12.74
Cancer and osteoarthritis 1,338 12.26 12.29 10.51, 14.06
Dementia and hypertension 1,203 12.88 12.88 11.00, 14.76
COPD and ischemic heart disease 7,235 15.59 15.03 13.76, 16.29
Cancer and hypertension 3,060 14.93 15.36 14.49, 16.24
Diabetes and COPD 1,704 16.61 16.56 14.78, 18.34
Cancer and ischemic heart disease 1,023 21.70 22.60 19.84, 25.36
Cancer and diabetes 1,253 24.34 24.90 22.45, 27.35
Cancer and COPD 1,860 39.84 40.41 38.07, 42.75
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with three or four chronic conditions. It was also apparent that
combining the conditions by simply using a count of the number
of conditions results in substantial loss of information regarding
the outcomes of patients with multiple chronic conditions. That
is, not all clusters of two conditions were equivalent, and the risk
of mortality was highly dependent on the conditions that
comprised the clusters. Therefore, when examining persons with
multiple coexisting conditions, it is important to understand the
components of a cluster, and it may be misleading to combine
groups based on the number of chronic conditions.
Unlike the previous work examining multiple chronic con-
ditions,
5,6 we focused on a limited number of chronic
conditions. Where Yu et al.
6 included 29 conditions, and Wolff
et al.
5 used 24 categories of diagnostic groups, we chose to
focus on 11 major conditions in creating our clusters of
diseases. The conditions we included are high prevalence and
high cost conditions in the United States and as such
represent high priority conditions for health care agencies.
Expansion of our list from these 11 conditions would have
resulted in a larger number of total clusters that patients could
have fallen into (there were 1,348 unique disease groups with
at least one patient in this analysis) and would have also
reduced the sample size in each of the clusters. However, by
focusing only on these conditions, we are essentially ignoring
the impact of other conditions that the patient may have and
that could affect both costs and the risk of mortality. For
example, if a condition occurred more frequently with one of
the conditions included in this analysis, we would be picking
up the effect of the condition that we measured as well as the
unmeasured condition.
There are other limitations to our analysis, one of which is
the fact that the classification of individuals into chronic
disease clusters was based on ICD-9 codes available at the
inception of the cohort, and subsequent development of disease
during the 5-year follow-up was not incorporated into the
analysis. As noted above, we did not consider other conditions
in creating our disease clusters nor did we use other diseases as
risk adjusters. We confined our analysis to veterans between 55
and 64 years to limit the effects of age on outcomes and to use a
population that was not yet eligible to receive Medicare services.
Therefore, the results are most generalizable to males in this age
range, and findings could be substantially different for females
and other ages. Only diagnoses that were associated with a VA
encounter or VA contracted services were used in the analysis,
and thus, if veterans were receiving care outside of the system,
these diagnoses were not captured. Finally, because we rely on
administrative data from a single year to characterize our cohort,
we are unable to accurately capture the duration and severity of
Table 4. Five-Year Mortality Rate Among Patients with Four
Conditions
Cluster 5-year mortality rate
Number Crude
(%)
Age
adjusted
(%)
95% CI
(%)
Ischemic heart disease
and hypertension and
diabetes and
osteoarthritis
3,821 9.40 9.37 8.42,
10.31
Ischemic heart disease
and hypertension and
COPD and
osteoarthritis
1,550 11.81 11.66 10.03,
13.30
Hypertension and
diabetes and COPD and
osteoarthritis
1,073 12.40 12.23 10.25,
14.20
Ischemic heart disease
and hypertension and
diabetes and depression
1,506 12.48 12.67 10.95,
14.39
Ischemic heart disease
and hypertension and
diabetes and stroke
1,850 16.97 16.77 15.03,
18.52
Ischemic heart disease
and hypertension and
diabetes and cancer
1,142 22.24 21.56 18.96,
24.15
Ischemic heart disease
and hypertension and
diabetes and COPD
3,204 22.38 22.33 20.86,
23.81
Table 3. Five-Year Mortality Rate Among Patients with Three
Conditions
Cluster 5-year mortality rate
Number Crude
(%)
Age
adjusted
(%)
95% CI
(%)
Hypertension and
depression and
osteoarthritis
1,959 3.88 4.16 3.16,
5.16
Ischemic heart disease
and hypertension and
osteoarthritis
5,945 4.61 4.52 3.99,
5.05
Hypertension and
diabetes and
osteoarthritis
9,136 5.32 5.30 4.84,
5.76
Ischemic heart disease
and hypertension and
depression
1,866 7.34 7.66 6.40,
8.92
Hypertension and
diabetes and
depression
2,782 7.84 8.17 7.06,
9.27
Hypertension and
COPD and asthma
1,159 8.28 8.36 6.75,
9.97
Hypertension and
COPD and
osteoarthritis
3,073 9.24 9.18 8.15,
10.20
Cancer and
hypertension and
osteoarthritis
1,433 9.49 9.40 7.82,
10.99
Ischemic heart disease
and stroke and
hypertension
2,025 10.47 10.49 9.11,
11.87
Ischemic heart disease
and hypertension and
diabetes
19,161 11.13 11.10 10.65,
11.55
Stroke and
hypertension and
diabetes
2,133 12.56 12.72 11.29,
14.16
Ischemic heart disease
and hypertension and
COPD
5,556 14.67 14.46 13.52,
15.40
Hypertension and
diabetes and COPD
3,687 15.30 15.20 14.02,
16.37
Ischemic heart disease
and cancer and
hypertension
1,804 16.74 17.65 15.70,
19.60
Cancer and
hypertension and
diabetes
2,809 17.84 18.05 16.53,
19.58
Cancer and
hypertension and
COPD
1,360 33.97 34.62 31.84,
37.40
406 Lee et al: Multiple Chronic Condition Mortality Rates JGIMdisease and the validity of ICD-9 codes in identifying diseases
likely varies. The risk of mortality within the selected age group
may be modified by the duration of disease, which is not
accounted for in this analysis. For example, the effect of diabetes
on mortality in persons included in this analysis may be very
different if the diabetes developed when the patient was 40 years
old compared to when they were 60 years old. In addition, if
severity of disease is associated with the presence of more
conditions, the increase in risk of mortality would be because of
a combination of disease severity and other conditions.
We found that patients with multiple chronic conditions in
the VA health care system represent a significant proportion of
VA patients and have an increased risk for mortality. Not
surprisingly, more conditions were associated with higher
rates of mortality; however, there was significant variation in
clusters with the same number of diseases. Thus, when
studying patients with multiple coexisting illnesses, it is
important to understand not only that several conditions may
be present but that the specific conditions can differentially
impact the risk of mortality.
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